Literature DB >> 8785408

Potential effect of metabolic acidosis on beta 2-microglobulin generation: in vivo and in vitro studies.

M Sonikian1, J Gogusev, J Zingraff, S Loric, B Quednau, G Bessou, W Siffert, T B Drüeke, H P Reusch, F C Luft.   

Abstract

Beta 2-microglobulin (beta 2M) is responsible for dialysis-associated amyloidosis. Level of beta 2M in plasma increase during chronic renal failure; however, retention does not appear to be the sole mechanism responsible. The effect of metabolic acidosis on beta 2M production was examined. Thirty-six patients with stable chronic renal insufficiency, 12 uremic patients before their first dialysis, 8 hemodialysis patients who were assigned to acetate or bicarbonate dialysate and then crossed over to the alternative regimen, and 6 normal subjects given NH4Cl to initiate metabolic acidosis were studied. In vitro studies in the human myeloid cell line U 937 were also performed. beta 2M protein was measured with ELISA, beta 2M mRNA was measured with reverse transcription polymerase chain reaction, and the U 937 cells were studied at two pH levels with FACScan flow cytometry. The cells were exposed in vitro up to 60 min in a buffered incubation medium to either pH 5.10 or pH 7.34. An inverse correlation was found between beta 2M and bicarbonate concentrations in plasma in the stable chronic renal failure patients (r = -0.54; P < 0.05) and in the uremic patients before their first dialysis (r = -0.72; P < 0.05). In hemodialysis patients, blood pH and plasma bicarbonate values were lower (P < 0.05) and beta 2M concentrations in plasma were higher (P < 0.05) with acetate than with bicarbonate dialysate. In normal men, NH4Cl resulted in an increase (P < 0.05) in beta 2M mRNA expression in lymphocytes by an average factor of 1.5 (range, 1.1 to 1.8). In U 937 cells, the cell surface expression of beta 2M and HLA Class I heavy chain assembled with beta 2M decreased at low pH compared with normal pH. Concomitantly, an increase in beta 2M release into the supernatant was observed, possibly as the result of beta 2M dissociation from cell surface HLA Class I complex. The results suggest that metabolic acidosis may enhance cellular beta 2M generation and release.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8785408     DOI: 10.1681/ASN.V72350

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  10 in total

Review 1.  Current status of bicarbonate in CKD.

Authors:  Mirela Dobre; Mahboob Rahman; Thomas H Hostetter
Journal:  J Am Soc Nephrol       Date:  2014-08-22       Impact factor: 10.121

2.  Role of bicarbonate supplementation on urine uric acid crystals and diabetic tubulopathy in adults with type 1 diabetes.

Authors:  Petter Bjornstad; David M Maahs; Carlos A Roncal; Janet K Snell-Bergeon; Viral N Shah; Tamara Milagres; Samuel L Ellis; Matthew Hatch; Linh T Chung; Marian J Rewers; Satish Garg; David Z Cherney; Laura Pyle; Kristen J Nadeau; Richard J Johnson
Journal:  Diabetes Obes Metab       Date:  2018-03-24       Impact factor: 6.577

Review 3.  Metabolic acidosis: pathophysiology, diagnosis and management.

Authors:  Jeffrey A Kraut; Nicolaos E Madias
Journal:  Nat Rev Nephrol       Date:  2010-03-23       Impact factor: 28.314

Review 4.  Metabolic Acidosis in Patients with CKD: Epidemiology, Pathogenesis, and Treatment.

Authors:  Marcin Adamczak; Stanisław Surma
Journal:  Kidney Dis (Basel)       Date:  2021-06-04

Review 5.  Beta-2 Microglobulin Amyloidosis: Past, Present, and Future.

Authors:  Ignacio Portales-Castillo; Jerry Yee; Hiroshi Tanaka; Andrew Z Fenves
Journal:  Kidney360       Date:  2020-10-21

Review 6.  Consequences and therapy of the metabolic acidosis of chronic kidney disease.

Authors:  Jeffrey A Kraut; Nicolaos E Madias
Journal:  Pediatr Nephrol       Date:  2010-06-05       Impact factor: 3.714

7.  Association of dialysate bicarbonate concentration with mortality in the Dialysis Outcomes and Practice Patterns Study (DOPPS).

Authors:  Francesca Tentori; Angelo Karaboyas; Bruce M Robinson; Hal Morgenstern; Jinyao Zhang; Ananda Sen; T Alp Ikizler; Hugh Rayner; Rachel B Fissell; Raymond Vanholder; Tadashi Tomo; Friedrich K Port
Journal:  Am J Kidney Dis       Date:  2013-05-24       Impact factor: 8.860

8.  The relationship between glycemic control, beta2-microglobulin and inflammation in patients on maintenance dialysis treatment.

Authors:  Vaia D Raikou; Despina Kyriaki
Journal:  J Diabetes Metab Disord       Date:  2015-04-23

9.  Glucose Serum Concentrations and Cardiovascular Disease in Patients on the End Stage of Renal Disease without Diabetes Mellitus.

Authors:  Vaia D Raikou; Despina Kyriaki
Journal:  J Cardiovasc Dev Dis       Date:  2015-04-24

10.  Mortality and Low Serum Bicarbonate Level in Patients on Hemodiafiltration versus Peritoneal Dialysis.

Authors:  V D Raikou; D Kyriaki
Journal:  Indian J Nephrol       Date:  2018 Mar-Apr
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.